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Abstract
Background: Brain-derived neurotrophic factor (BDNF) is associated with body weight and other health con-
ditions but remains understudied in the Latino population. The aim of this study was to examine the associations
of BDNF serum levels with body mass index (BMI), physical activity, and the rs6265 nonconservative poly-
morphism among 349 Latinos aged ‡18 years enrolled in the Arizona Insulin Resistance Registry.
Materials and Methods: Data on physical activity were acquired using a self-reported questionnaire. BDNF
serum levels were measured utilizing a modified ELISA method, and the rs6265 polymorphism was genotyped
by the Assay-by-Design service. Two sample t-tests or chi-squared tests were employed to compare demo-
graphics and outcomes between physically active and nonactive groups as well as between rs6265 CC and
CT+TT groups.
Results: BDNF levels and rs6265 polymorphism did not differ significantly between the physically active
(N = 195) and nonactive group (N = 154). Participants with the rs6265 polymorphism did not show any sig-
nificant difference in BDNF levels or BMI when compared with those with the normal functional variant.
Higher BDNF levels were significantly associated with higher age (r = 0.11, P = 0.04) and higher 2-hr glucose
level (r = 0.11, P = 0.04).
Conclusions: In this cross-sectional study, the rs6265 polymorphism was not associated with a higher risk of
obesity, or lower circulating levels of BDNF. Thus, the rs6265 polymorphism may have a different impact in
Latinos as compared with other previously studied populations.
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Introduction
Brain-derived neurotrophic factor (BDNF) playsan important role in the development, regulation, and
survival of neurons in the hippocampus, and other structures
relevant to cognitive function.1 BDNF deficiency has been
associated with neurocognitive disorders and metabolic
diseases.2–5 Furthermore, BDNF is also associated with
physical activity.6–11 Although the exact mechanism of ac-
tion remains unknown, it has been hypothesized that BDNF
could be one factor accounting for the beneficial effects of
physical activity on neurocognitive function, by promoting
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cell growth and survival in the hippocampal neurons.6 In
addition, interaction effects between genetics with physical
activity and metabolic parameters have been reported.7
BDNF is implicated in the regulation of food intake and
body weight, by suppressing food intake through hippo-
campal signaling and enhancing energy expenditure.5,8,9
Although the pathology of obesity is multifactorial, studies
have reported an inverse association between lower BDNF
serum concentration and higher body mass index (BMI) and
percentage of body fat.10–12
The BDNF gene is located on chromosome 11p14.1.
Considerable allele and haplotype diversity in the BDNF
gene has been observed among different ethnic popula-
tions. It has been reported that there is a specific genetic
variant within the gene that may influence the risk of obe-
sity, Alzheimer’s disease, cognitive impairment, and other
health conditions.8,13–17 There is a well-identified single nu-
cleotide polymorphism (SNP) expressed in the pro-region of
the BDNF gene on position 66 (change from valine to me-
thionine): rs6265.14 This change results in aberrant sorting
of BDNF into secretory vesicles and decreased activity-
dependent secretion.14 The rs6265 variant is of particular
interest, because it is the only known frequent nonconser-
vative polymorphism in the BDNF gene12 and is associated
with various health conditions, such as obesity and type 2
diabetes.12,15,18
To date, the majority of BDNF studies have been con-
ducted in animal models.5,9,19,20 The few published human
studies predominantly involve Caucasian or Asian popula-
tions and reported conflicting results on the associations
between health conditions, particularly obesity, and the
rs6265 polymorphism.10,12,15,18 The association of the
rs6265 SNP and BMI has not been described among Latinos
who are the fastest growing minority group in the United
States.21 Latinos are disproportionately affected by obesity
and have a high prevalence of chronic diseases such as di-
abetes and cardiovascular disease.22 According to the Na-
tional Hispanic Council on Aging, Latinos engage in less
physical activity than non-Hispanic whites, which may put
them at higher risk for metabolic disorders.23,24 Therefore,
the aim of our study was to investigate the cross-sectional
associations between the BDNF rs6265 polymorphism,
physical activity, and BMI among a community-based
sample of Latinos residing in Phoenix, Arizona. We hy-
pothesized that higher serum BDNF levels would be asso-
ciated with a higher level of physical activity and lower
BMI. In addition, we hypothesized that there would be a
higher frequency of the BDNF rs6265 mutation among




This study utilized existing stored biospecimens and
previously collected data from participants enrolled in the
Arizona Insulin Resistance Registry. In brief, individuals
who identified themselves as Latino or Mexican American
between the ages of 18 and 85 years were recruited through
community clinics, flyers, and word of mouth.25 Participants
completed a detailed medical history and an intake ques-
tionnaire. Engagement in physical activity was assessed
through one item from the intake questionnaire: ‘‘Do you
participate in exercise? Yes/No.’’ If participants answered
‘‘yes,’’ then further details were obtained regarding inten-
sity, frequency, and duration. The physical examination
included anthropometric measures (height, weight, and
waist circumference), seated blood pressure, fasting labo-
ratory measures (comprehensive metabolic and lipid panel),
and an oral glucose tolerance test. In addition, participants
provided consent to collect and bank fasting serum, DNA,
and RNA for future use. All data were entered into a
searchable REDCap database and biospecimens were
stored at -80C in individual aliquots at Arizona State
University (ASU) laboratories, housed in the Mayo Clinic
Arizona campus. The study was approved by the Institu-
tional Review Board of Arizona State University. Written
informed consent was obtained from each participant be-
fore participation.
Laboratory procedure
We used Mayo Clinic’s Biospecimens Accessioning and
Processing laboratory to process the BDNF assays. BDNF
levels were measured in the serum, given that serum BDNF
levels are reflective of brain BDNF.26 To analyze serum
BDNF levels, we used a modified ELISA method.27 SNP
genotyping for rs6265 was performed by the Assay-by-
Design service (Applied Biosystems, CA.), as previously
described.28 In brief, in a 384-well plate, 2 mL of purified
genomic DNA (2 ng/mL) were incubated with primers and
probes with the SNP of interest (0.09 mL), 3.5 mL of TaqMan
Universal Polymerase Chain Reaction Master Mix-No
AmpErase UNG, and 1.14 mL of distilled water. Samples
were polymerase-chain-reaction-amplified on the Applied
Biosystems 9700HT Thermal Cycler under the following
conditions: denatured for 10 min at 95C, denatured, an-
nealed, and extended for 40 cycles of 15 s at 92C and 1 min
at 60C. The 384-well microplates were scanned for fluo-
rescence emission using a 7900HT sequence detector (Ap-
plied Biosystems), and alleles were scored using the allelic
discrimination software Sequence Detection System v2.3
(Applied Biosystems).
Statistical analysis
Age, BMI, fasting glucose, 2-hr glucose, and serum
BDNF levels of participants who reported physical activ-
ity versus those who did not report physical activity were
compared using two-sample t-test. Gender and rs6265
SNP groups (i.e., CC, CT, and TT) were compared be-
tween physically active and nonactive participants using
chi-squared test. Additional statistical comparisons be-
tween groups (i.e., between CC and CT+TT combined
rs6265 genotype groups) were made by using the two-
sample t-test or chi-squared test. The associations between
BDNF and age, BMI, and glucose (fasting or 2-hr) were
quantified by using the Pearson correlation coefficient. With
225 patients in the CC group, and 118 patients in the CT+TT
group, we have 80% power to detect an effect size 0.32 or
larger (small to medium effect size) in a continuous phe-
notype trait between the two groups, assuming a 0.05 two-
sided significance level. Statistical testing was performed at
the conventional two-tailed a = 0.05 using SAS software
Version 9.3 (SAS Institute, Inc.).
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Results
Data were available on 349 participants (233 women and
116 men) with a mean age of 42 years. Mean (–SD) BDNF
levels did not differ (P = 0.89) between men (33 – 16 ng/mL)
and women (33 – 17 ng/mL). There were 195 participants
(56%) who reported engaging in regular physical activity
(i.e., ‘‘active group’’). The active group had a significantly
smaller proportion of women, and a lower mean BMI than
the nonactive group. Mean BDNF levels did not differ
significantly between the active and nonactive group
(D = -1 ng/mL, 95% CI -4 to 3, P = 0.64). Information on
rs6265 genotype was available for 343 participants. Two
hundred twenty-five participants (64%) were CC homozy-
gous for the functional variant, 109 (31%) were CT het-
erozygous, and 9 (3%) were TT homozygous for the
mutation. The minor allele frequency in our population was
0.1851. There was no significant difference in rs6265 ge-
notype frequency between the physically active and non-
active group. Adjusting for age, gender, BMI, fasting
glucose, or 2-hr glucose did not alter the results (Table 1).
Mean BDNF levels did not differ between the CC and CT
genotypes. Similarly, there were no differences regarding
any other demographic characteristics between CC and CT
genotypes (Table 2). Higher BDNF levels were significantly
associated with higher age (r = 0.11, P = 0.04) and higher
2-hr glucose level (r = 0.11, P = 0.04; Fig. 1). In addition,
there was a marginally significant association between higher
BDNF levels and higher fasting glucose levels (r = 0.10,
P = 0.07). BDNF level was not associated with BMI (r = -0.05,
P = 0.36).
Discussion
Building upon the growing body of research on BDNF
and its implication among different populations, we sought
to determine the cross-sectional association between BDNF
serum levels with BMI, physical activity, and the rs6265
polymorphism in a convenience sample of Latinos residing
in Phoenix, Arizona. We observed that physical activity and
the rs6265 polymorphism did not have any significant as-
sociation with BDNF serum concentrations. In addition, the
rs6265 polymorphism was also not associated with BMI in
our sample.
To date, we have not identified a study that examined the
association between rs6265 BDNF polymorphism and
physical activity or BMI among Latinos. Given that physical
activity is associated with increased BDNF expression,
Table 1. Demographics, Body Mass Index, Glucose, and Brain-Derived Neurotrophic Factor Levels;
Stratified by Physical Activity Group
Active
Yes (N = 195) No (N = 154) D 95% CI P
Women 118 (61%) 115 (75%) -14.2% -23.9 to -4.5 0.005
Age (years); mean (SD) 41.7 (8.3) 41.5 (9.4) 0.2 (8.8) -1.7 to 2.1 0.82
BMI (kg/m2); mean (SD) 29.5 (4.9) 31.9 (7.5) -2.3 (6.2) -3.6 to -1.0 <0.001
Glucose (mg/dL)
Fasting; mean (SD) 96 (31) 99 (40) -3 (34) -10 to 4 0.41
2-Hr; mean (SD) 140 (61) [N 189] 150 (70) [N 150] -11 (65) -25 to 3 0.13
rs6265
N 193 150 0.46
CC 123 (64%) 102 (68%)
CT 66 (34%) 43 (29%)
TT 4 (2%) 5 (3%)
BDNF (ng/mL); mean (SD) 33 (16) 34 (17) -1 (16) -4 to 3 0.64
D, difference in means between active and nonactive groups; BDNF, brain-derived neurotrophic factor serum level; BMI, body mass
index; 95% CI, 95% confidence interval; CC, CC homozygotes; CT, CT heterozygotes; rs6265, rs6265 single nucleotide polymorphism;
SD, standard deviation; TT, TT homozygotes.
Table 2. Demographics, Body Mass Index, Glucose, and Brain-Derived Neurotrophic Factor Levels;
Stratified by CC and CT+TT rs6265 Genotype Group
CC CT+TT
D 95% CI P(N = 225) (N = 118)
Women 151 (67.1%) 77 (65.3%) 1.9% -8.7 to 12.4 0.73
Age (years); mean (SD) 41.3 (8.5) 42.4 (9.4) -1.1 (8.8) -3.1 to 0.9 0.26
BMI (kg/m2); mean (SD) 30.5 (6.5) 30.7 (5.7) -0.2 (6.2) -1.6 to 1.2 0.80
Obese (BMI ‡30) 101 (44.9%) 57 (48.3%) -3.4% -14.5 to 7.7 0.55
Glucose (mg/dL)
Fasting; mean (SD) 99 (35) 96 (33) 3 (34) -5 to 11 0.46
2-Hr; mean (SD) 146 (70) [N 220] 141 (56) [N 113] 5 (66) -9 to 19 0.46
Active 123 (54.7%) 70 (59.3%) -4.7% -15.6 to 6.3 0.41
BDNF (ng/mL); mean (SD) 34 (17) 32 (15) 1 (16) -2 to 5 0.49
D, difference in means between CC homozygotes and CT heterozygotes.
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primarily in the hippocampus,19,29,30 we hypothesized that a
higher level of physical activity would be associated with
higher BDNF concentrations. However, we did not observe
a significant difference in BDNF levels between the physi-
cally active and nonactive group. This may in part be ex-
plained by the relatively high BMI of the participants
(including those who reported physical activity), which was
mostly at overweight or obese levels. This is relevant since
BMI has been reported to be directly affected by secreted
levels of BDNF, undermining any potential effect that
physical activity could have on BDNF expression.5 Another
possible explanation is that BDNF response is transient after
acute exercise and does not have a lasting effect.31,32 In our
study we did not measure BDNF after an acute bout of
exercise, rather we used a survey to acquire data on regular
physical activity.33 This may explain the absence of dif-
ference in BDNF levels between the physically active and
nonactive group in our study.
We also investigated the association between the rs6265
SNP and serum BDNF level among Latinos. The frequency
and distribution of methionine carriers (CT and TT) in our
sample is consistent with previous studies that report BDNF
genotype distributions in primarily non-Hispanic white
samples.34 In our study, mean BDNF levels did not vary
between CC and CT genotypes. Similar studies conducted in
Chinese and Indian35,36 populations reported that BDNF
levels are not affected by the rs6265 polymorphism, sup-
porting our findings that BDNF levels may not vary by
genotype status.
Furthermore, we did not observe an association between
the rs6265 polymorphism and BMI in our study sample.
There are conflicting results as to whether rs6265 genotype
is associated with BMI across populations.12,13,15,18 For
example, investigators from Mexico found that the rs6265
polymorphism confers a lower risk for obesity.16 However,
a study in a Boston Puerto Rican sample reported a gender-
specific association, that is, CC men had twice the risk of
being overweight, whereas CC women had a lower mean
BMI.8 Whereas we did not observe any gender- or age-
specific associations, which could in part be explained by
the fact that our population was on average 10 years younger
than the Puerto Rican sample.
Finally, we observed weak correlations between BDNF
levels with glucose levels and age. BDNF has been reported
to impact metabolism of peripheral organs,2 and as a result,
BDNF may be elevated after glucose ingestion, possibly
playing a role in body weight balance.11 As for the associ-
ation with age, further research is needed to determine the
cause of the relationship with BDNF, since independent age-
related increase has been reported in only one study.37
There are other possible explanations for the discrepancies
between this study’s findings and previous reports. For ex-
ample, lifestyle factors such as low physical activity and
poor diet may contribute to high obesity rates among Latinos
and may also interact with genetic effects. In addition, poor
socioeconomic status and long working hours may make it
more difficult to adhere to healthy lifestyles and diet. Fur-
thermore, lack of education may be a risk factor for meta-
bolic syndrome and other chronic diseases. Finally, genetic
variability may be another explanation. As mentioned ear-
lier, most studies have used European and Caucasian sam-
ples and distribution of genotypes and phenotypes may differ
between populations.
Our findings should be interpreted within the context of
strengths and limitations of this study. The strengths of our
study include a relatively large, community-based, low so-
cioeconomic sample of Latino participants residing in Ar-
izona. The main limitation of this study is a lack of genetic
markers that would have enabled us to provide information
on the ancestry groups or genetic substructure of our non-
homogenous sample. Furthermore, we were not able to rule
out potential bias that may stem from genetic admixture or
population stratification. However, potential bias due to
these factors may be of less relevance to our study since we
are not reporting a positive finding. The cross-sectional
design is one of the limitations of our study. Such a design
FIG. 1. Correlation be-
tween BDNF serum level
(in ng/mL) and 2-hr glucose
level (in mg/dL). BDNF,
brain-derived neurotrophic
factor.
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does not indicate the direction of causality. In addition,
physical activity was assessed using a survey that may be
susceptible to recall bias.
In summary, in this cross-sectional study among Latinos
residing in Phoenix, Arizona, serum BDNF levels were not
significantly associated with physical activity, BMI, or the
rs6265 polymorphism. The rs6265 polymorphism was not
associated with a higher risk of obesity or lower circulating
levels of BDNF. Thus, the rs6265 polymorphism may have
a different impact in Latinos as compared with other pre-
viously studied populations. Future prospective studies in a
larger sample of Latinos are needed to confirm this pre-
liminary finding.
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